KIT and gastrointestinal stromal tumor: Many possible causes underlying imatinib resistance in GIST are widely acknowledged, including the emergence of secondary mutations in KIT kinase domains, unknown effects of gene polymorphisms, activation of alternative cell death pathways and so on.6, 7, 28